EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Unveiling the enigma: a case-based review of scleromyxedema

Jagoda Rogowska iD, Filip Styrzyński iD, Joanna Makowska iD, Olga Brzezińska iD

Rheumatology International · 2025

DOI: 10.1007/s00296-024-05775-2 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Rheumatology International, 2025. Verfasst von Jagoda Rogowska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Medical University of Lodz, Łódź, Poland. Hauptthemen laut MEDLINE: Scleromyxedema, Immunoglobulins, Intravenous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scleromyxedema is a rare chronic fibromucinous disorder characterized by a generalized papular and sclerodermoid eruption. Despite its clinical significance, no definitive therapeutic guidelines exist for scleromyxedema, making management challenging. Herein, we present a case of a 76-year-old female patient referred for evaluation of systemic sclerosis, presenting with distinctive cutaneous manifestations and neurological symptoms. Investigations revealed monoclonal gammopathy (IgG Lambda subtype) and antinuclear antibodies, supporting a diagnosis of scleromyxedema. A multidisciplinary approach with intravenous immunoglobulin (IVIG) therapy resulted in significant improvement in neurological and cutaneous symptoms. This case underscores the challenges of diagnosing and managing scleromyxedema and highlights IVIG as a potential therapeutic option in the absence of standardized guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ScleromyxedemaImmunoglobulins, IntravenousHumansFemaleAgedTreatment OutcomeAntibodies, Antinuclear

Stichwörter der Autor:innen

Fibromucinous disorderIntravenous immunoglobulin (IVIG)Monoclonal gammopathyMultidisciplinary managementScleromyxedema

Substanzen

Immunoglobulins, IntravenousAntibodies, Antinuclear

Autor:innen und Institutionen

  • Department of Rheumatology, Medical University of Lodz, Łódź, Poland.
  • Department of Rheumatology, Medical University of Lodz, Łódź, Poland. filip.styrzynski@umed.lodz.pl.

ORCID-Profile: Jagoda Rogowska, Filip Styrzyński, Joanna Makowska, Olga Brzezińska

Zitieren

APA

Rogowska, J., Styrzyński, F., Makowska, J., & Brzezińska, O. (2025). Unveiling the enigma: a case-based review of scleromyxedema. Rheumatology International. https://doi.org/10.1007/s00296-024-05775-2

Vancouver

Rogowska J, Styrzyński F, Makowska J, Brzezińska O. Unveiling the enigma: a case-based review of scleromyxedema. Rheumatology International. 2025. doi:10.1007/s00296-024-05775-2

BibTeX
@article{Rogowska2025,
  author = {Rogowska, Jagoda and Styrzyński, Filip and Makowska, Joanna and Brzezińska, Olga},
  title = {Unveiling the enigma: a case-based review of scleromyxedema},
  journal = {Rheumatology International},
  year = {2025},
  doi = {10.1007/s00296-024-05775-2}
}
Kostenlos starten →